IDEAYA Biosciences, Inc. <IDYA.O>: Leerink Partners cuts target price to $31 from $37
IDYA•Related News
Korea Fund files Form 3 as David A. Buttke Jr. joins as chief compliance officer
KF•
Ball Corp raises target price to $66 from $65
BALL•
Hudson Pacific Properties Q2 revenue beats on higher occupancy
HPP•
Revolve Group Inc <RVLV.N>: UBS raises target price to $29 from $28
RVLV•
Cummins Inc <CMI.N>: UBS cuts target price to $835 from $850
CMI•